In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtronic's Brainstorm in Neurology

Executive Summary

Medtronic's neurology business grew out of its cardiology technology and has become its fastest growing unit. Now the company is learning how to be a marketing pioneer.

You may also be interested in...

Northstar's Buzz

The hottest clinical space in medical devices may very well be stroke and the hottest technology area could be neurostimulation. Northstar combines both opportunities with an innovative system that addresses a largely un-addressed market--chronic stroke--by stimulating the cortex of the brain. And as promising as this therapy is, it may only be the tip of the iceberg for Northstar

Keeping Leadership Real: An Interview with Bill George

At a time when the US industry is undergoing perhaps its most serious crisis of leadership and confidence, it was appropriate that Bill George, former chairman and CEO of Medtronic was the recipient of the Lifetime Achievement award at this year's Phoenix Medical Device and Diagnostic conference for CEOs, sponsored by PricewaterhouseCoopers, Versant Ventures, Wilson Sonsini Goodrich & Rosati, and Windhover Information. Honoring Bill George at this particular time is propitious because George has spent his career promoting the importance of individual values and responsibility in corporate leadership, and has just published "Authentic Leadership: Rediscovering the Secrets to Creating Lasting Value," a book that defines the qualities he considers essential attributes for corporate leaders to successfully manage companies built to deliver long-term value.

ANS Goes Along For The Ride

Most small medical device companies develop innovative proprietary technology in hopes of unseating much larger rivals--on the theory that physicians care more about the effectiveness of the technology than who makes it. But Advanced Neuromodulation Systems sees things differently. Its main competition is device giant Medtronic, which not only leads in terms of market share, but has been a technology innovator. ANS's play: not to defeat Medtronic at its own game, but to carve out a lucrative part of the chronic pain management market under Medtronic's radar.

Related Content


Related Companies

Related Deals

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts